We identified a novel mechanism of hereditary thrombosis associated with antithrombin resistance, with a substitution of arginine for leucine at position 596 (p.Arg596Leu) in the gene encoding ...
Molecular biologists have discovered a way to harness the enzyme thrombin's anti-blood clotting properties. In research led by a Saint Louis University investigator, molecular biologists have ...
An interdisciplinary team of researchers from North Carolina State University and the University of North Carolina at Chapel Hill has developed a smart patch designed to monitor a patient's blood and ...
The developing thrombus in a living mouse after vessel-wall injury (Panel A) is characterized by the deposition of platelets (red), tissue factor (green), and fibrin (blue). Platelet thrombus ...
17 Jan 2008 , Leverkusen : Bayer HealthCare announced today that its partner, ZymoGenetics Inc., received US Food and Drug Administration (FDA) approval of RECOTHROMâ„¢ Thrombin, topical (recombinant) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results